マーケットレポート詳細
RNA解析の世界市場：技術別、用途別2028年予測
RNA Analysis Market by Product (Reagents, Instruments, Software, Services), Technology (PCR, Sequencing, Microarrays, RNA Interference), Application (Drug Discovery, Clinical Diagnostics), End User (Pharma, Biotech, CROs), Region - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年7月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文257ページになります。
- 商品コード：MAM3357
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
RNA解析の世界市場規模は2023年で53億ドル、2028年に99億ドル、市場の平均年成長率は13.4%増で推移すると予測されています。
レポートはRNA解析の世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品/サービス別市場、技術別市場、等）を中心に構成されています。また競合状況、主要企業情報（15社）、エコシステム分析、特許分析などの分析も加味し、RNA解析市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆RNA解析の世界市場予測2021-2028年
・市場規模(US$)
◆製品/サービス別、市場-2028年
・試薬/消耗品
・器具
・ソフトウェア
・サービス
※(市場規模US$)
◆技術別、市場-2028年
・ポリメラーゼ連鎖反応
・シーケンシング
・マイクロアレイ
・RNAi（RNA干渉）
※(市場規模US$)
◆用途別、市場-2028年
・創薬
・臨床診断
・トキシコゲノミクス
・比較トランスクリプトミクス
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・製薬/バイオテクノロジー企業
・病院/診断センター
・学術機関/研究機関
・開発業務受託機関（CRO）
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン、スイス
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメントの細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・バリューチェーン分析
・サプライチェーン分析
・エコシステム分析
・特許分析
・技術分析
・業界構造分析
・競合状況
・市場シェア分析
◆RNA解析の主要企業プロフィール動向
・THERMO FISHER SCIENTIFIC INC
・F HOFFMANN-LA ROCHE LTD
・BIO-RAD LABORATORIES, INC
・ILLUMINA, INC
・EUROFINS SCIENTIFIC
・AGILENT TECHNOLOGIES, INC
・CD GENOMICS
・PROMEGA CORPORATION
・QIAGEN NV
・DANAHER CORPORATION
・MERCK KGAA
・STANDARD BIOTOOLS INC (FLUIDIGM CORPORATION)
・SEQUENTIA BIOTECH SL
・ACOBIOM
・GENXPRO GMBH
その他企業
・LEXOGEN GMBH
・CENIX BIOSCIENCE GMBH
・宝ホールディングス株式会社
・BIOMÉRIEUX SA
・LC SCIENCES LLC
・OXFORD NANOPORE TECHNOLOGIES
・ZYMO RESEARCH CORPORATION
・GENEDX
・PARTEK INCORPORATED
・BGI GROUP
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS 30
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT 31
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
・ FIGURE 2 RNA ANALYSIS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
・ FIGURE 3 RNA ANALYSIS MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2022)
・ FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
・ FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARIES
・ FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, TECHNOLOGY, APPLICATION, AND END USER)
・ FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
・ FIGURE 8 RNA ANALYSIS MARKET: CAGR PROJECTIONS, 2023–2028
・ FIGURE 9 RNA ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 IMPACT OF ECONOMIC RECESSION ON RNA ANALYSIS MARKET
・ TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2028 (% GROWTH)
・ TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
・ TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
・ FIGURE 11 RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 RNA ANALYSIS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 RNA ANALYSIS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 14 RNA ANALYSIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 15 GEOGRAPHICAL SNAPSHOT: RNA ANALYSIS MARKET
4 PREMIUM INSIGHTS
4.1 RNA ANALYSIS MARKET OVERVIEW
・ FIGURE 16 RISING INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: RNA ANALYSIS MARKET SHARE, BY APPLICATION & COUNTRY (2022)
・ FIGURE 17 DRUG DISCOVERY APPLICATIONS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN RNA ANALYSIS MARKET IN 2022
4.3 RNA ANALYSIS MARKET SHARE, BY END USER, 2022
・ FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.4 RNA ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN RNA ANALYSIS MARKET FROM 2023 TO 2028
4.5 RNA ANALYSIS MARKET, BY REGION (2023–2028)
・ FIGURE 20 NORTH AMERICA TO CONTINUE TO DOMINATE RNA ANALYSIS
MARKET UNTIL 2028
4.6 RNA ANALYSIS MARKET: DEVELOPED VS. EMERGING ECONOMIES
・ FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 22 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・ TABLE 4 RNA ANALYSIS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 GROWING DEMAND FOR PERSONALIZED MEDICINE
・ FIGURE 23 PERSONALIZED MEDICINES APPROVED BY FDA, 2015–2022
5.2.1.2 RISING PHARMACEUTICAL AND BIOTECHNOLOGY R&D EXPENDITURE AND GOVERNMENT FUNDING
・ FIGURE 24 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
5.2.1.3 INCREASING APPLICATIONS OF RNA SEQUENCING IN TRANSCRIPTOMICS
5.2.2 RESTRAINTS
5.2.2.1 HIGH CAPITAL INVESTMENTS
5.2.3 OPPORTUNITIES
5.2.3.1 HIGH GROWTH OPPORTUNITIES IN EMERGING MARKETS
5.2.3.2 INCREASING APPLICATIONS IN TOXICOGENOMICS
5.2.3.3 INCREASING FOCUS ON BIOMARKER DISCOVERY
5.2.3.4 RISING FOCUS ON OUTSOURCING
5.2.4 CHALLENGES
5.2.4.1 DATA MANAGEMENT IN TRANSCRIPTOMICS RESEARCH 63
5.2.4.2 LACK OF EFFECTIVE BIOINFORMATICS TOOLS
5.2.4.3 DEARTH OF SKILLED PROFESSIONALS
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 VALUE CHAIN ANALYSIS
・ FIGURE 25 VALUE CHAIN ANALYSIS OF RNA ANALYSIS MARKET: RESEARCH AND MANUFACTURING PHASES CONTRIBUTE MAXIMUM VALUE
5.5 SUPPLY CHAIN ANALYSIS
・ FIGURE 26 RNA ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
・ TABLE 5 SUPPLY CHAIN ECOSYSTEM
5.7 PATENT ANALYSIS
・ FIGURE 27 PATENT APPLICATIONS FOR RNA ANALYSIS MARKET, JUNE 2012–JUNE 2023
5.8 LIST OF MAJOR PATENTS
5.9 TECHNOLOGY ANALYSIS
・ TABLE 6 COMPARISON OF MODERN RNA ANALYSIS METHODS
5.10 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 7 RNA ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF SUPPLIERS
5.10.4 BARGAINING POWER OF BUYERS
5.10.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.11 REGULATORY ANALYSIS
5.11.1 REGULATIONS FOR RNA ANALYSIS PRODUCTS
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 KEY CONFERENCES AND EVENTS IN 2023
・ TABLE 11 RNA ANALYSIS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RNA ANALYSIS PRODUCTS
5.13.2 BUYING CRITERIA 80
・ FIGURE 29 KEY BUYING CRITERIA FOR END USERS
6 RNA ANALYSIS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
・ TABLE 12 RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 REAGENTS/CONSUMABLES
6.2.1 REAGENTS/CONSUMABLES TO DOMINATE MARKET DURING FORECAST PERIOD
・ TABLE 13 RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY REGION,
2021–2028 (USD MILLION)
・ TABLE 14 NORTH AMERICA: RNA ANALYSIS REAGENTS/CONSUMABLES MARKET,
BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 15 EUROPE: RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 16 ASIA PACIFIC: RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 INSTRUMENTS 86
6.3.1 GROWING NEED FOR ACCURATE ANALYSIS TO DRIVE ADOPTION OF AUTOMATED INSTRUMENTS
・ TABLE 17 RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 18 NORTH AMERICA: RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 19 EUROPE: RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 20 ASIA PACIFIC: RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SOFTWARE
6.4.1 GROWING NEED FOR DATA MANAGEMENT AND QUALITY ENHANCEMENTS TO DRIVE DEMAND FOR SOFTWARE SOLUTIONS
・ TABLE 21 RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 22 NORTH AMERICA: RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 23 EUROPE: RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 24 ASIA PACIFIC: RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 SERVICES
6.5.1 INCREASING OUTSOURCING OF SERVICES TO PROPEL MARKET GROWTH
・ TABLE 25 RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 26 NORTH AMERICA: RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 27 EUROPE: RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 28 ASIA PACIFIC: RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 RNA ANALYSIS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
・ TABLE 29 RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
7.2 POLYMERASE CHAIN REACTION
7.2.1 ABILITY OF REAL-TIME PCR TO AID IN QUANTIFICATION OF LOW-COPY TRANSCRIPTS TO BOOST DEMAND 96
・ TABLE 30 RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 31 NORTH AMERICA: RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 32 EUROPE: RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 33 ASIA PACIFIC: RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 SEQUENCING 99
7.3.1 ADVANCES IN NGS MULTIPLEXING CAPABILITIES TO AID MARKET GROWTH
・ TABLE 34 RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 35 NORTH AMERICA: RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 36 EUROPE: RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 37 ASIA PACIFIC: RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 MICROARRAYS 103
7.4.1 WIDE ADOPTION OF MICROARRAYS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH
・ TABLE 38 RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 39 NORTH AMERICA: RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 40 EUROPE: RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 41 ASIA PACIFIC: RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 RNA INTERFERENCE
7.5.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT ADOPTION OF TECHNIQUE FOR DIAGNOSTICS AND THERAPEUTICS 106
・ TABLE 42 RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 43 NORTH AMERICA: RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 44 EUROPE: RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 45 ASIA PACIFIC: RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
8 RNA ANALYSIS MARKET, BY APPLICATION
8.1 INTRODUCTION
・ TABLE 46 RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 DRUG DISCOVERY
8.2.1 GROWING POPULARITY OF TARGETED SEQUENCING-BASED APPROACHES IN DRUG DISCOVERY TO BOOST MARKET
・ TABLE 47 RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 48 NORTH AMERICA: RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 49 EUROPE: RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 50 ASIA PACIFIC: RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 CLINICAL DIAGNOSTICS
8.3.1 GROWING ADOPTION OF TRANSCRIPTOMICS FOR LARGE-SCALE GENE EXPRESSION PROFILING OF ONCOLOGICAL DISORDERS TO FUEL GROWTH
・ TABLE 51 RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 52 NORTH AMERICA: RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 53 EUROPE: RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 54 ASIA PACIFIC: RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 TOXICOGENOMICS
8.4.1 GROWING FOCUS ON ADR STUDIES TO DRIVE ADOPTION OF TRANSCRIPTOMICS FOR SYSTEMIC TOXICOLOGY
・ TABLE 55 RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 56 NORTH AMERICA: RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 57 EUROPE: RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 58 ASIA PACIFIC: RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 COMPARATIVE TRANSCRIPTOMICS
8.5.1 WIDE ADOPTION OF TRANSCRIPTIONAL PROFILES TO STUDY EVOLUTION AMONG SPECIES TO PROPEL GROWTH
・ TABLE 59 RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 60 NORTH AMERICA: RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 61 EUROPE: RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 62 ASIA PACIFIC: RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
9 RNA ANALYSIS MARKET, BY END USER
9.1 INTRODUCTION
・ TABLE 63 RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 INCREASING INVESTMENTS FOR ONCOLOGY THERAPEUTICS TO DRIVE USE OF OMICS TECHNOLOGIES IN PHARMA & BIOTECH COMPANIES
・ TABLE 64 RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 65 NORTH AMERICA: RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 66 EUROPE: RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 67 ASIA PACIFIC: RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 HOSPITALS & DIAGNOSTIC CENTERS
9.3.1 USE OF WHOLE-BLOOD TRANSCRIPTOME PROFILES FOR DISEASE DIAGNOSTICS TO FAVOR MARKET GROWTH 127
・ TABLE 68 RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 69 NORTH AMERICA: RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 70 EUROPE: RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 129
・ TABLE 71 ASIA PACIFIC: RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 ACADEMIC & RESEARCH INSTITUTES
9.4.1 GROWING GOVERNMENT INVESTMENTS TO PROPEL MARKET GROWTH
・ TABLE 72 RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 73 NORTH AMERICA: RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 74 EUROPE: RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 75 ASIA PACIFIC: RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 CONTRACT RESEARCH ORGANIZATIONS
9.5.1 GROWING OUTSOURCING OF SERVICES BY PHARMACEUTICAL COMPANIES FOR FASTER DRUG DISCOVERY TO AID MARKET GROWTH
・ TABLE 76 RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 77 NORTH AMERICA: RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 78 EUROPE: RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 79 ASIA PACIFIC: RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
10 RNA ANALYSIS MARKET, BY REGION
10.1 INTRODUCTION
・ TABLE 80 RNA ANALYSIS MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
・ FIGURE 30 NORTH AMERICA: RNA ANALYSIS MARKET SNAPSHOT
・ TABLE 81 NORTH AMERICA: RNA ANALYSIS MARKET, BY COUNTRY, 2021–2028(USD MILLION)
・ TABLE 82 NORTH AMERICA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 83 NORTH AMERICA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 84 NORTH AMERICA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 85 NORTH AMERICA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 US TO DOMINATE NORTH AMERICAN RNA ANALYSIS MARKET DURING FORECAST PERIOD
・ TABLE 86 US: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 87 US: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 88 US: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 89 US: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 IMPROVING FUNDING AND INFRASTRUCTURE FOR OMICS-BASED RESEARCH TO SUPPORT MARKET GROWTH
・ TABLE 90 CANADA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 91 CANADA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 92 CANADA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 93 CANADA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
・ TABLE 94 EUROPE: RNA ANALYSIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 95 EUROPE: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 96 EUROPE: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 97 EUROPE: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 98 EUROPE: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 GERMANY TO HOLD LARGEST SHARE OF EUROPEAN RNA ANALYSIS MARKET DURING FORECAST PERIOD
・ TABLE 99 GERMANY: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 100 GERMANY: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 101 GERMANY: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 102 GERMANY: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 RISING PUBLIC AND PRIVATE FUNDING FOR RESEARCH TO DRIVE MARKET GROWTH 154
・ TABLE 103 UK: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 104 UK: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 105 UK: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 106 UK: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 INCREASING GOVERNMENT SUPPORT FOR OMICS-BASED RESEARCH TO SUPPORT MARKET GROWTH
・ TABLE 107 FRANCE: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 108 FRANCE: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 109 FRANCE: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 110 FRANCE: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 IMPROVING R&D EXPENDITURE AND DISEASE DIAGNOSTICS TO BOOST MARKET
・ TABLE 111 ITALY: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 112 ITALY: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 113 ITALY: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 114 ITALY: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 INCREASING COLLABORATIONS FOR ENHANCING RESEARCH TO SUPPORT MARKET GROWTH
・ TABLE 115 SPAIN: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 116 SPAIN: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 117 SPAIN: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 118 SPAIN: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 SWITZERLAND
10.3.6.1 WELL-ESTABLISHED PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH
・ TABLE 119 SWITZERLAND: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 120 SWITZERLAND: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 121 SWITZERLAND: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 122 SWITZERLAND: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 REST OF EUROPE
・ TABLE 123 REST OF EUROPE: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 124 REST OF EUROPE: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 125 REST OF EUROPE: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 126 REST OF EUROPE: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4 EUROPE: RECESSION IMPACT
10.5 ASIA PACIFIC
・ FIGURE 31 ASIA PACIFIC: RNA ANALYSIS MARKET SNAPSHOT
・ TABLE 127 ASIA PACIFIC: RNA ANALYSIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 128 ASIA PACIFIC: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 129 ASIA PACIFIC: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 130 ASIA PACIFIC: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 131 ASIA PACIFIC: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.1 CHINA
10.5.1.1 CHINA TO BE FASTEST-GROWING MARKET IN ASIA PACIFIC DURING FORECAST PERIOD
・ TABLE 132 CHINA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 133 CHINA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 134 CHINA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 135 CHINA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 JAPAN
10.5.2.1 EARLY ADOPTION OF TECHNOLOGICALLY ADVANCED PRODUCTS TO DRIVE MARKET GROWTH
・ TABLE 136 JAPAN: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 137 JAPAN: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 138 JAPAN: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 139 JAPAN: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.3 INDIA
10.5.3.1 INCREASING PHARMACEUTICAL R&D SPENDING AND GOVERNMENT FUNDING FOR RESEARCH TO DRIVE MARKET GROWTH
・ TABLE 140 INDIA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 141 INDIA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 142 INDIA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 143 INDIA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.4 REST OF ASIA PACIFIC
・ TABLE 144 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 145 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 146 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 147 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6 ASIA PACIFIC: RECESSION IMPACT
10.7 LATIN AMERICA
10.7.1 GROWTH IN PHARMACEUTICAL INDUSTRY IN MEXICO TO SUPPORT MARKET GROWTH
・ TABLE 148 LATIN AMERICA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 149 LATIN AMERICA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 150 LATIN AMERICA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 151 LATIN AMERICA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.8 LATIN AMERICA: RECESSION IMPACT
10.9 MIDDLE EAST & AFRICA
10.9.1 IMPROVING FOCUS ON PRECISION MEDICINE AND DISEASE GENETICS TO DRIVE MARKET GROWTH
・ TABLE 152 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 153 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 154 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 155 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.10 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
・ FIGURE 32 RNA ANALYSIS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS
・ FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
11.4 MARKET SHARE ANALYSIS
・ FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
・ TABLE 156 RNA ANALYSIS MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS
・ FIGURE 35 RNA ANALYSIS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.6.1 COMPANY PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
・ TABLE 157 COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN RNA ANALYSIS MARKET
11.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
・ TABLE 158 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN RNA ANALYSIS MARKET
11.7 COMPANY EVALUATION QUADRANT: STARTUPS/SMES
・ FIGURE 36 RNA ANALYSIS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/ SMES, 2022
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
11.8 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
・ TABLE 159 RNA ANALYSIS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
・ TABLE 160 RNA ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 PRODUCT LAUNCHES 203
・ TABLE 161 RNA ANALYSIS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2020–JUNE 2023
11.9.2 DEALS
・ TABLE 162 RNA ANALYSIS MARKET: DEALS, JANUARY 2020–JUNE 2023
11.9.3 OTHER DEVELOPMENTS
・ TABLE 163 RNA ANALYSIS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023
12 COMPANY PROFILES
12.1 KEY PLAYERS 206
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
12.1.1 THERMO FISHER SCIENTIFIC INC.
・ TABLE 164 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
・ FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
12.1.2 F. HOFFMANN-LA ROCHE LTD.
・ TABLE 165 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
・ FIGURE 38 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
12.1.3 BIO-RAD LABORATORIES, INC.
・ TABLE 166 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
・ FIGURE 39 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
12.1.4 ILLUMINA, INC.
・ TABLE 167 ILLUMINA, INC.: COMPANY OVERVIEW
・ FIGURE 40 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
12.1.5 EUROFINS SCIENTIFIC
・ TABLE 168 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
・ FIGURE 41 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
12.1.6 AGILENT TECHNOLOGIES, INC.
・ TABLE 169 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
・ FIGURE 42 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
12.1.7 CD GENOMICS
・ TABLE 170 CD GENOMICS: COMPANY OVERVIEW
12.1.8 PROMEGA CORPORATION
・ TABLE 171 PROMEGA CORPORATION: COMPANY OVERVIEW
12.1.9 QIAGEN N.V.
・ TABLE 172 QIAGEN N.V.: COMPANY OVERVIEW
・ FIGURE 43 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
12.1.10 DANAHER CORPORATION
・ TABLE 173 DANAHER CORPORATION: COMPANY OVERVIEW
・ FIGURE 44 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
12.1.11 MERCK KGAA
・ TABLE 174 MERCK KGAA: BUSINESS OVERVIEW
・ FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2022)
12.1.12 STANDARD BIOTOOLS INC. (FLUIDIGM CORPORATION)
・ TABLE 175 STANDARD BIOTOOLS INC.: BUSINESS OVERVIEW
・ FIGURE 46 STANDARD BIOTOOLS INC.: COMPANY SNAPSHOT (2022)
12.1.13 SEQUENTIA BIOTECH SL
・ TABLE 176 SEQUENTIA BIOTECH SL: BUSINESS OVERVIEW
12.1.14 ACOBIOM
・ TABLE 177 ACOBIOM: BUSINESS OVERVIEW 246
12.1.15 GENXPRO GMBH
・ TABLE 178 GENXPRO GMBH: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 LEXOGEN GMBH
12.2.2 CENIX BIOSCIENCE GMBH
12.2.3 TAKARA HOLDINGS INC.
12.2.4 BIOMÉRIEUX SA
12.2.5 LC SCIENCES LLC 252
12.2.6 OXFORD NANOPORE TECHNOLOGIES
12.2.7 ZYMO RESEARCH CORPORATION
12.2.8 GENEDX
12.2.9 PARTEK INCORPORATED
12.2.10 BGI GROUP
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.